Cargando…
P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429483/ http://dx.doi.org/10.1097/01.HS9.0000847304.04017.68 |
| _version_ | 1784779457926529024 |
|---|---|
| author | Bessudo, A. Greenwald, D. Kazemi, M. H. Mahindra, A. Shunyakov, L. Sondhi, M. O’Connor, H. Chen, Y. Yang, J. Salles, G. |
| author_facet | Bessudo, A. Greenwald, D. Kazemi, M. H. Mahindra, A. Shunyakov, L. Sondhi, M. O’Connor, H. Chen, Y. Yang, J. Salles, G. |
| author_sort | Bessudo, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429483 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94294832022-08-31 P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES Bessudo, A. Greenwald, D. Kazemi, M. H. Mahindra, A. Shunyakov, L. Sondhi, M. O’Connor, H. Chen, Y. Yang, J. Salles, G. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429483/ http://dx.doi.org/10.1097/01.HS9.0000847304.04017.68 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bessudo, A. Greenwald, D. Kazemi, M. H. Mahindra, A. Shunyakov, L. Sondhi, M. O’Connor, H. Chen, Y. Yang, J. Salles, G. P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title | P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title_full | P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title_fullStr | P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title_full_unstemmed | P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title_short | P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES |
| title_sort | p1109: trial in progress: phase 1b/2 trial of tazemetostat in combination with various treatments in patients with relapsed or refractory hematologic malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429483/ http://dx.doi.org/10.1097/01.HS9.0000847304.04017.68 |
| work_keys_str_mv | AT bessudoa p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT greenwaldd p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT kazemimh p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT mahindraa p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT shunyakovl p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT sondhim p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT oconnorh p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT cheny p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT yangj p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies AT sallesg p1109trialinprogressphase1b2trialoftazemetostatincombinationwithvarioustreatmentsinpatientswithrelapsedorrefractoryhematologicmalignancies |